Latest News

Next generation TB test receives approval from key global review panel

Emerging Omicron Variant Reinforces the Role of Rapid Antigen Testing

QIAGEN receives U.S. FDA emergency use authorization for rapid portable SARS-CoV-2 antigen test

Why Aussie startup Ellume’s home-testing tech should help us in the COVID-19 recovery, but can’t

An Australian firm producing home COVID-19 tests for the U.S. market has called on the federal government to reconsider its ban

Rapid COVID-19 Testing Device, Sunrise Interview with Ellume CEO Dr Sean Parsons

Alaska Airlines Partners with AZOVA to Provide Ellume COVID-19 Home Tests & Video Observation for Safe, Healthy Travel

New rapid COVID testing options coming to Delta; Purchase and pack for smooth U.S. re-entry

Channel 10’s new Advancing Australia series features Ellume CEO Dr Sean Parsons

What Role Will At-Home COVID-19 Tests Play in an Increasingly Vaccinated World?

Ellume and Cambridge Consultants Collaborate on Core Technology Behind Ellume’s Rapid Antigen COVID-19 Test

FDA authorizes Ellume COVID-19 Home Test as First Over-the-Counter Fully At-Home Diagnostic Test

Ellume’s COVID-19 Home Test shows 96% accuracy in multi-site US clinical study

Ellume enlists Bosch Australia to automate manufacturing for high-performance COVID-19 Test

Ellume awarded US$30M from U.S. National Institutes of Health RADx initiative to accelerate development of rapid COVID-19 diagnostics

Ellume announces high-performance test for active COVID-19 infection

Experts push for faster coronavirus tests to help Australia adapt to a new ‘COVID-normal’

Ellume announces global partnership with QIAGEN for COVID-19 diagnosis

Meet the Aussie entrepreneur letting you diagnose the flu through your smartphone

Ellume announces another global partnership with QIAGEN on the detection of tuberculosis